Nexalin Technology Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nexalin Technology Stock Summary

Nexalin Technology competes with Ainos, Electromed, SurModics, Bluejay Diagnostics, and IRIDEX. Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company was incorporated in 2021 and is headquartered in Houston, Texas. Nexalin Technology operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Nexalin Technology Key Financial Ratios

Nexalin Technology Key Balance Sheet Accounts

Nexalin Technology Key Income Statement Accounts

Nexalin Technology Key Cash Accounts

Nexalin Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nexalin Technology's current stock value. Our valuation model uses many indicators to compare Nexalin Technology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nexalin Technology competition to find correlations between indicators driving Nexalin Technology's intrinsic value. More Info.Nexalin Technology is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Nexalin Technology's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Nexalin Technology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Nexalin Technology Systematic Risk

Today, most investors in Nexalin Technology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nexalin Technology's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nexalin Technology growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nexalin Technology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nexalin Technology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nexalin Technology based on widely used predictive technical indicators. In general, we focus on analyzing Nexalin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nexalin Technology's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.